TARRYTOWN, N.Y. (AP) — TARRYTOWN, N.Y. (AP) — Regeneron Pharmaceuticals Inc. (REGN) on Friday reported fourth-quarter profit of $844.6 million.
The Tarrytown, New York-based company said it had net income of $7.86 per share. Earnings, adjusted for stock option expense and non-recurring costs, came to $11.44 per share.
The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $10.56 per share.
The biopharmaceutical company posted revenue of $3.88 billion in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $3.82 billion.
For the year, the company reported profit of $4.5 billion, or $41.48 per share. Revenue was reported as $14.34 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGN
/Advanced%20Micro%20Devices%20Inc_%20logo%20on%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
/Chipset%20held%20over%20rush%20hour%20traffic%20by%20Jae%20Young%20Ju%20via%20iStock.jpg)
/Qualcomm%2C%20Inc_%20logo%20on%20phone-by%20viewimage%20via%20Shutterstock.jpg)
